Two Third Party GMP Audits performed in Germany by API Compliance Institute
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The API Compliance Institute recently performed Third Party GMP Audits at two API manufacturing sites in Germany. The Audits were initiated by a group of Qualified Persons and QA Managers from different pharmaceutical companies who are using the respective APIs to manufacture their medicinal products. The initiators as well as the Auditee agreed to share the audit reports with other companies.
The GMP Audits were performed by 2 certified APIC Auditors during 2 days at each manufacturing site. They were conducted according to the rules of the APIC Audit Programme. This GMP Audit Scheme is an internationally recognized auditing programme which was established 10 years ago. It is the idea of the programme to share compliance information between companies.
The following sites were audited:
Site: Excella GmbH
Nürnberger Str. 12
90537 Feucht
and
Site: Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Str. 173
55216 Ingelheim
The API Compliance Institute is responsible for the controlled distribution of the audit report in which the GMP compliance situation at the two API manufacturing sites has been described in detail. More information can be obtained from the following source: Press Release API Compliance Insitute
Related GMP News
27.04.2026FDA remains active in Europe - further Inspections despite MRAs
22.04.2026No Validation, No Controls, and No Suitable Rooms and Equipment - Extensive Warning Letter
25.03.2026FDA Warning Letter highlights once again: Weaknesses in the CAPA Process remain a key GMP Issue
18.03.2026FDA Issues Draft Guidance on Responding to Form 483 Observations
28.01.2026What is the Procedure for GMP Inspections (EU GMP inspections and FDA Inspections)?
21.01.2026FDA Warning Letter highlights critical Failures in Supplier and Quality Oversight